Cancer BiologyBritish Journal of CancerPeer-reviewed
Reactivation of DRP1 plays a functional role in resistance to MEK inhibition in pancreatic cancer cells
Salma Sharmin, Jennifer A. Kashatus, Sara J. Adair…·David F. Kashatus
This study identifies DRP1 reactivation as a mechanism of resistance to MEK inhibition in pancreatic cancer cells and shows that inhibiting DRP1 can restore sensitivity to trametinib.
DOI 10.1038/s41416-026-03542-7